Companies/EU/969500XPWN2D

GENFIT

GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA). Employees 188 Sector Biotechnology & Medical Research Calendar Earnings release - Q2 2026

Index membership

Loading…

Listed venues

4 markets

Home listing plus other exchanges for the same issuer (scoped aliases).